Preliminary scientific studies show conolidine might inhibit certain ion channels, lowering neuronal excitability and limiting soreness indicators. This system is especially applicable in neuropathic discomfort, in which abnormal signaling leads to persistent irritation. Additionally, conolidine appears to impact G protein-coupled receptor (GPCR) p